LENVATINIB and DIARRHOEA

Overview

DIARRHOEA is the #1 most commonly reported adverse reaction for LENVATINIB, manufactured by Eisai Inc.. There are 3,869 FDA adverse event reports linking LENVATINIB to DIARRHOEA. This represents approximately 6.0% of all 64,104 adverse event reports for this drug.

Patients taking LENVATINIB who experience diarrhoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DIARRHOEA is moderately reported among LENVATINIB users, representing a notable but not dominant share of adverse events.

Other Side Effects of LENVATINIB

In addition to diarrhoea, the following adverse reactions have been reported for LENVATINIB:

• HYPERTENSION — 3,419 reports
• FATIGUE — 3,124 reports
• DECREASED APPETITE — 2,970 reports
• NAUSEA — 2,312 reports
• MALIGNANT NEOPLASM PROGRESSION — 2,165 reports
• BLOOD PRESSURE INCREASED — 2,011 reports
• VOMITING — 1,880 reports
• ASTHENIA — 1,534 reports
• DEHYDRATION — 1,460 reports
• WEIGHT DECREASED — 1,366 reports

Other Drugs Associated with DIARRHOEA

The following drugs have also been linked to diarrhoea in FDA adverse event reports:

Does LENVATINIB cause DIARRHOEA?

DIARRHOEA has been reported as an adverse event in 3,869 FDA reports for LENVATINIB. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DIARRHOEA with LENVATINIB?

DIARRHOEA accounts for approximately 6.0% of all adverse event reports for LENVATINIB, making it one of the most commonly reported side effect.

What should I do if I experience DIARRHOEA while taking LENVATINIB?

If you experience diarrhoea while taking LENVATINIB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages